Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

RX-3117

SKU: orb1307765

Description

RX-3117 is a novel fluorocyclopentenylcytosine analog with demonstrated anticancer activity in vitro against various cancer cell lines, including those resistant to gemcitabine. Research applications include investigating its mechanism and efficacy in preclinical in vivo models for oncology.

Research Area

Cell Biology, Molecular Biology

Images & Validation

Key Properties

CAS Number865838-26-2
MW257.22
Purity99.55% (May vary between batches)
FormulaC10H12FN3O4
SMILESNc1ccn([C@H]2[C@H](O)[C@H](O)C(CO)=C2F)c(=O)n1
TargetApoptosis,Nucleoside Antimetabolite/Analog
SolubilityDMSO:50 mg/mL (194.39 mM)

Bioactivity

In Vivo
RX-3117 (p.o.) was examined in 9 different human tumor xenograft models grown subcutaneously in athymic nude mice. In the Colo 205, H460, H69 and CaSki models, gemcitabine treatment resulted in 28%, 30%, 25% and 0% tumor growth inhibition (TGI), respectively. Whereas oral treatment with RX-3117 induced 100%, 78%, 62% and 66% TGI, respectively .
In Vitro
RX-3117 was a very poor substrate for cytidine deaminase (66,000-fold less than gemcitabine). RX-3117 showed a different sensitivity profile compared to cyclopentenyl-cytosine and azacytidine, substrates for uridine-cytidine-kinase. Insensitive U937 cells 1 μM RX-3117 resulted in 90% inhibition of RNA synthesis but 100 μM RX-3117 was required in A2780 and CCRF-CEM cells. RX-3117 at IC50 values did not affect the integrity of RNA .

Storage & Handling

Storagestore at low temperature,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

TV1360, TV-1360, TV 1360, RX 3117, RX3117, RX-3117, S phase, DNMT1, apoptosis, antiproliferative, anti-tumour, Analog, fluorocyclopentenylcytosine, Inhibitor, inhibit, NucleosideAntimetabolite, Nucleoside Antimetabolite/Analog, Nucleoside Antimetabolite, orally active
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

RX-3117 (orb1307765)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

1 mg
¥ 2,600.00
2 mg
¥ 3,510.00
5 mg
¥ 4,810.00
1 ml x 10 mM (in DMSO)
¥ 4,940.00
10 mg
¥ 6,630.00
25 mg
¥ 10,530.00
50 mg
¥ 14,430.00
100 mg
¥ 19,370.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry